Alaunos Therapeutics, Inc.

TCRT

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001107421

SEC filings (opens in a new tab)

No open-market purchases or sales by Alaunos Therapeutics, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $204.4K in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Alaunos Therapeutics, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021 All holders in Q3 2021

13F holders of TCRT: Q3 2021 compared with Q4 2021
Measure	Q3 2021	Of which not filed for Q4 2021	Q4 2021	Change
Holders	163	2	167	+6
Shares	106.6M	941.1K	142.9M	+37.3M (+35.3%)
Value	$194.1M	$1.71M	$155.9M	−$36.5M (−19.0%)

2 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (26)

Institutions that held Alaunos Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to TCRT in Q4 2021
Institution	Shares	Value	% of portfolio
AXA S.A.	877,500	$956.0K	0.00%
Fuller & Thaler Asset Management, Inc.	787,890	$859.0K	0.00%
Wellington Management Group LLP	756,169	$824.0K	0.00%
Qube Research & Technologies Ltd	379,766	$414.0K	0.00%
Caxton Associates LP	141,254	$154.0K	0.02%
Alpine Global Management, LLC	115,605	$126.0K	0.02%
Allspring Global Investments Holdings, LLC	106,983	$116.0K	0.00%
Manteio Capital LLC	104,787	$114.0K	0.15%
XTX Topco Ltd	44,172	$48.0K	0.03%
AdvisorNet Financial, Inc	39,393	$43.0K	0.00%
ExodusPoint Capital Management, LP	30,397	$33.0K	0.00%
Pathway Financial Advisors LLC	29,000	$31.0K	0.01%
Engineers Gate Manager LP	27,445	$30.0K	0.00%
Greenleaf Trust	12,688	$14.0K	0.00%
QCM Cayman, Ltd.	11,187	$12.0K	0.07%
Freestone Capital Holdings, LLC	10,000	$11.0K	0.00%
Masso Torrence Wealth Management Inc.	5,000	$5.00K	0.00%
Aquatic Capital Management LLC	3,800	$4.00K	0.01%
PFS Partners, LLC	1,000	$1.09K	0.00%
Northwestern Mutual Wealth Management Co	614	$1.00K	0.00%
Equitec Proprietary Markets, LLC	1,023	$1.00K	0.00%
Widmann Financial Services, Inc.	1,400	$1.00K	0.00%
Estabrook Capital Management	850	$927	0.00%
Harbor Investment Advisory, LLC	385	$0	0.00%
Trustcore Financial Services, LLC	250	$0	0.00%
Schubert & Co	104	$0	0.00%

Sold out (20)

Institutions that held Alaunos Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of TCRT in Q4 2021
Institution	Shares, Q3 2021	Value, Q3 2021
State of Wisconsin Investment Board	286,900	$522.0K
Ergoteles LLC	214,000	$389.0K
Exencial Wealth Advisors, LLC	170,779	$311.0K
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.	97,119	$177.0K
SkyOak Wealth, LLC	84,466	$154.0K
DekaBank Deutsche Girozentrale	70,000	$133.0K
Sargent Investment Group, LLC	30,000	$55.0K
Gateway Advisory, LLC	15,301	$28.0K
Five Oceans Advisors	15,307	$28.0K
Cetera Advisors LLC	14,258	$26.0K
We Are One Seven, LLC	14,200	$21.0K
Wetherby Asset Management Inc	10,410	$19.0K
Meeder Asset Management Inc	5,326	$10.0K
Penserra Capital Management LLC	4,935	$8.00K
O'Shaughnessy Asset Management, LLC	2,583	$5.00K
Parallel Advisors, LLC	2,978	$5.00K
Lindbrook Capital, LLC	1,721	$3.00K
Sargent Bickham Lagudis LLC	300	$1.00K
IFP Advisors, Inc	197	$1.00K
FourThought Financial, LLC	500	$1.00K

Not filed for Q4 2021 yet (2)

Institutions that held Alaunos Therapeutics, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding TCRT in Q3 2021 that haven't filed for Q4 2021
Institution	Shares, Q3 2021	Value, Q3 2021
Marshall Wace North America L.P.	939,821	$1.71M
Berman Capital Advisors, LLC	1,284	$2.00K